Covid 19 Research Articles

Brig. Gen. Michael J. Talley
-------
"vaccines in mice to see what their response is and making sure it's safe,” Dr. Kayvon Modjarrad, director of Emerging Infectious Diseases at Walter Reed Army Institute of Research said.

A research team from China’s People’s Liberation Army (PLA) have also reported achieving a breakthrough in the vaccine development earlier this week. It includes development of an adenovirus vector vaccine for COVID-19 and a class 1 biological drug with full intellectual property rights, which can be used to treat not only COVID-19 patients, but also people who have been exposed to the virus as an emergency prevention measure.

Modjarrad said he didn't want to speculate when human testing would begin. But he said that the next phase would be testing in larger animals that are more similar to humans, including monkeys."
https://www.defenseworld.net/news/26472/US_Army_Medics_Begin_Coronavirus__COVID_19__Vaccine_Testing#.XrK7i_BOmyU

Date of article 3/6/2020

Here is a link to studies, trials, alternative medicine on Covid 19 for all over the world,
1,254 studies. External links included
https://clinicaltrials.gov/ct2/results?cond=COVID-19

For Canadians, that first OP is from March the 6th... as in 6/3/20... two months ago.

Lots of action going on but no positive results yet.

The U.S. Food and Drug Administration (FDA) has granted both Fast Track and Breakthrough Therapy Designation to DAS181. It is currently being tested in a worldwide, multicenter Phase III clinical trial for the treatment of hospitalized, immunocompromised patients with lower respiratory tract parainfluenza virus infections (STOP PIV). The drug is also being tested in a Phase IIb clinical trial in China for the treatment of severe hospitalized influenza infections (STOP FLU). DAS181 has been dosed in over 800 patients ranging from infancy to age 77.
https://www.biospace.com/article/releases/ansun-biopharma-enrolls-first-patient-in-proof-of-concept-trial-of-das181-for-the-treatment-of-covid-19/

Infection Control.

Leading medical centers funded to train and prepare other U.S. health care facilities for emerging special pathogens, including COVID-19.
https://repository.netecweb.org/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control

Asymptomatic carriers Info
https://repository.netecweb.org/items/show/979